174 related articles for article (PubMed ID: 2033058)
1. Suramin. A potent inhibitor of melanoma heparanase and invasion.
Nakajima M; DeChavigny A; Johnson CE; Hamada J; Stein CA; Nicolson GL
J Biol Chem; 1991 May; 266(15):9661-6. PubMed ID: 2033058
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues.
Marchetti D; Reiland J; Erwin B; Roy M
Int J Cancer; 2003 Mar; 104(2):167-74. PubMed ID: 12569571
[TBL] [Abstract][Full Text] [Related]
3. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
Irimura T; Nakajima M; Nicolson GL
Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
6. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
Savion N; Disatnik MH; Nevo Z
J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides.
Miao HQ; Elkin M; Aingorn E; Ishai-Michaeli R; Stein CA; Vlodavsky I
Int J Cancer; 1999 Oct; 83(3):424-31. PubMed ID: 10495437
[TBL] [Abstract][Full Text] [Related]
8. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
Marchetti D; Liu S; Spohn WC; Carson DD
J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
[TBL] [Abstract][Full Text] [Related]
9. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; Nicolson GL
Adv Enzyme Regul; 1997; 37():111-34. PubMed ID: 9381967
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production.
Marchetti D; Menter D; Jin L; Nakajima M; Nicolson GL
Int J Cancer; 1993 Oct; 55(4):692-9. PubMed ID: 8407001
[TBL] [Abstract][Full Text] [Related]
12. Heparanases and tumor metastasis.
Nakajima M; Irimura T; Nicolson GL
J Cell Biochem; 1988 Feb; 36(2):157-67. PubMed ID: 3281960
[TBL] [Abstract][Full Text] [Related]
13. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties.
Lapierre F; Holme K; Lam L; Tressler RJ; Storm N; Wee J; Stack RJ; Castellot J; Tyrrell DJ
Glycobiology; 1996 Apr; 6(3):355-66. PubMed ID: 8724143
[TBL] [Abstract][Full Text] [Related]
14. Human melanoma cell invasion: selected neurotrophin enhancement of invasion and heparanase activity.
Marchetti D; Nicolson GL
J Investig Dermatol Symp Proc; 1997 Aug; 2(1):99-105. PubMed ID: 9487024
[TBL] [Abstract][Full Text] [Related]
15. Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase.
Schoenfeld AK; Vierfuß S; Lühn S; Alban S
J Pharm Biomed Anal; 2014 Jul; 95():130-8. PubMed ID: 24667567
[TBL] [Abstract][Full Text] [Related]
16. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D
J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
[TBL] [Abstract][Full Text] [Related]
17. Tumor metastasis-associated heparanase (heparan sulfate endoglycosidase) activity in human melanoma cells.
Nakajima M; Irimura T; Nicolson GL
Cancer Lett; 1986 Jun; 31(3):277-83. PubMed ID: 3719568
[TBL] [Abstract][Full Text] [Related]
18. Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma.
Dua P; Ingle A; Gude RP
Int J Cancer; 2007 Oct; 121(7):1600-8. PubMed ID: 17582610
[TBL] [Abstract][Full Text] [Related]
19. Immunochemical localization of heparanase in mouse and human melanomas.
Jin L; Nakajima M; Nicolson GL
Int J Cancer; 1990 Jun; 45(6):1088-95. PubMed ID: 2351486
[TBL] [Abstract][Full Text] [Related]
20. Heparanase expression in B16 melanoma cells and peripheral blood neutrophils before and after extravasation detected by novel anti-mouse heparanase monoclonal antibodies.
Komatsu N; Waki M; Sue M; Tokuda C; Kasaoka T; Nakajima M; Higashi N; Irimura T
J Immunol Methods; 2008 Feb; 331(1-2):82-93. PubMed ID: 18162185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
